Live
- Ensure action against illegal mining in Aravali range: Gurugram DC
- Collector Directs Swift Action on Prajavani Complaints; Unveils Anti-Drug Campaign Posters
- Ayush market grew $43.4 bn in 2023, exports doubled to $2.16 bn: Shripad Yesso Naik
- Ambuja Cements partners Finland-based Coolbrook towards Net Zero goals
- First Neuro, Wins Best Stroke Ready Hospital of The Year Award
- South Korean President vows to ease burden on small merchants from delivery platform commissions
- Centre should ensure release of Bengal fishermen jailed in B’desh: Mamata Banerjee
- Kerala Police Recover Over Rs 1 Crore, Gold In Major Theft Case; Gulf Returnee Arrested
- Namrata launches new poster of ‘Mufasa: The Lion King’
- India Condemns Breach At Bangladesh Mission In Tripura Amid Hindu Protection Protests
CCMB team sees decrease in Covid-19 deaths
CCMB team sees decrease in Covid-19 deaths
A study says no clade at present is associated with a more severe form of Covid-19 or an increased risk of death in India
Hyderabad: Scientists at the CSIR-Centre for Cellular and Molecular Biology (CCMB), Hyderabad have analysed more than 2,000 SARS-CoV-2 genomes from India available in the public domain to understand various strains in circulation.
Earlier in June, the team had revealed the presence of a distinct virus population among Indians. This was named the clade I/A3i and is recognised by the presence of four specific variations in their genetic makeup (genomes). At that time, 41% of all Indian SARS-CoV-2 genomes belonged to this clade.
The current analysis showed that the proportion of the A3i clade dropped to 18%. "One of the 4 distinct variations that define the A3i clade is present in a key viral enzyme called RDRP, involved in making new copies of the viral RNA. This variant was predicted to be deleterious or bad for the virus, and if the prediction is indeed correct, we expected A3i clade to slowly disappear with time, and other clades without this variation will prevail. This is exactly what we see now", said Dr Divya Tej Sowpati, Scientist at CCMB, who is leading this study here.
The decrease in the proportion of A3i clade is accompanied by an increase of the A2a clade, also referred to as the G clade or the 20A/B/C clades in other nomenclatures. Viruses of the A2a or the G clade carry the D614G mutation in their spike protein which is shown to be associated with an increased infectivity. At present 70% of all Indian as well as global SARS-CoV-2 genomes fall into this clade.
"As expected for a strain which is more infectious, A2a clade quickly became the dominant clade in India just like everywhere else. There is no evidence to state that this mutation is clinically a more difficult one. The similarity in viral genome globally should be considered a positive news, because a vaccine or a drug targeting this mutation will work with the same effectiveness all over the world," says Dr Rakesh K Mishra, Director, CCMB and a co-author of the study.
It is, however, important to note that no clade at present has been conclusively shown to be associated with a more severe form of Covid-19, or an increased risk of death. The findings of the study done with scientists from CSIR-Institute of Integrative Biology as collaborators, are now peer-reviewed and published in the journal Open Forum Infectious Diseases published by the Oxford University Press.
